Hostname: page-component-78c5997874-94fs2 Total loading time: 0 Render date: 2024-11-19T11:01:12.643Z Has data issue: false hasContentIssue false

ECT-treatment in Western Norway; first data from the Regional register of neurostimulation treatment

Published online by Cambridge University Press:  23 March 2020

U. Kessler*
Affiliation:
Haukeland university hospital, clinic for psychosomatic medicine, Bergen, Norway
H. Schoeyen
Affiliation:
Stavanger university hospital, department of psychiatry, Stavangerno, Norway
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Electroconvulsive therapy (ECT) is one of the most polarizing treatments in medicine. Although the treatment effect is well documented in clinical studies, there is a lack of data regarding patients treated in an ordinary clinical setting. In 2013, we established a regional register of neurostimulation treatment in Western Norway.

Objectives

To describe the use of ECT at the Haukeland university hospital in Bergen.

Methods

Patients treated with ECT between June 2013 and June 2015 were included in the register.

Results

One hundred and forty-seven patients received ECT during the 2 years period. The mean age was 58.4 years (22–91 years), 67% were female. Half of the patients (49.7%) had been treated with ECT previously. Indication for treatment was depression in 137 patients (93.2%), of which 29 (19.7%) were moderately, and 69 patients (46.9%) severely depressed, and additional 37 patients (25.2%) presented with severe depression with psychotic features. All but two patients were treated with right unilateral electrode placement, with a mean of 9.7 (3–22) treatments.

The mean MADRS before treatment was 34.2 (4–56) and after treatment 11.9 (0–39). One hundred and ten patients (74.8%) responded to treatment; of which 89 (60.5%) remitted (response defined as a 50% or greater decrease from MADRS baseline score, remission defined as MADRS ≤ 12). Twenty patients (13%) continued with continuation or maintenance ECT after the index series.

Disclosure of interest

The authors have not supplied their declaration of competing interest.

Type
EW457
Copyright
Copyright © European Psychiatric Association 2014
Submit a response

Comments

No Comments have been published for this article.